Last updated on November 2017

Type 2 Diabetes and treated with NPH or basal insulin


Brief description of study

Type 2 Diabetes and treated with NPH or basal insulin

Detailed Study Description

A 15 month clinical research study is evaluating if a new investigational basal insulin dosed once daily can provide safe and effective blood sugar control compared to a marketed basal insulin dosed once daily in people with type 2 diabetes.

Qualified participants will receive all study-related care and study medication at no cost and may be compensated for travel.

Clinical Study Identifier: TX81572

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Robert Rossi

Beacon Clinical Research
Quincy, MA USA
  Connect »